QIS

· Adimmune Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QIS, covering 2019-09-24 to 2019-09-24. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety Evaluation of QIS in Healthy Subjects [Phase 3]